The DOI matches its Crossref record; 642 of the 642 references it cites were found in a registry or an index.
How does adenosine control neuronal dysfunction and neurodegeneration?
Abstract
The adenosine modulation system mostly operates through inhibitory A 1 (A 1 R) and facilitatory A 2A receptors (A 2A R) in the brain. The activity‐dependent release of adenosine acts as a brake of excitatory transmission through A 1 R, which are enriched in glutamatergic terminals. Adenosine sharpens salience of information encoding in neuronal circuits: high‐frequency stimulation triggers ATP release in the ‘activated’ synapse, which is locally converted by ecto‐nucleotidases into adenosine to selectively activate A 2A R; A 2A R switch off A 1 R and CB1 receptors, bolster glutamate release and NMDA receptors to assist increasing synaptic plasticity in the ‘activated’ synapse; the parallel engagement of the astrocytic syncytium releases adenosine further inhibiting neighboring synapses, thus sharpening the encoded plastic change. Brain insults trigger a large outflow of adenosine and ATP, as a danger signal. A 1 R are a hurdle for damage initiation, but they desensitize upon prolonged activation. However, if the insult is near‐threshold and/or of short‐duration, A 1 R trigger preconditioning, which may limit the spread of damage. Brain insults also up‐regulate A 2A R, probably to bolster adaptive changes, but this heightens brain damage since A 2A R blockade affords neuroprotection in models of epilepsy, depression, Alzheimer's, or Parkinson's disease. This initially involves a control of synaptotoxicity by neuronal A 2A R, whereas astrocytic and microglia A 2A R might control the spread of damage. The A 2A R signaling mechanisms are largely unknown since A 2A R are pleiotropic, coupling to different G proteins and non‐canonical pathways to control the viability of glutamatergic synapses, neuroinflammation, mitochondria function, and cytoskeleton dynamics. Thus, simultaneously bolstering A 1 R preconditioning and preventing excessive A 2A R function might afford maximal neuroprotection. image The main physiological role of the adenosine modulation system is to sharp the salience of information encoding through a combined action of adenosine A 2A receptors (A 2A R) in the synapse undergoing an alteration of synaptic efficiency with an increased inhibitory action of A 1 R in all surrounding synapses. Brain insults trigger an up‐regulation of A 2A R in an attempt to bolster adaptive plasticity together with adenosine release and A 1 R desensitization; this favors synaptotocity (increased A 2A R) and decreases the hurdle to undergo degeneration (decreased A 1 R). Maximal neuroprotection is expected to result from a combined A 2A R blockade and increased A 1 R activation. This article is part of a mini review series: “Synaptic Function and Dysfunction in Brain Diseases”.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–400 of 642
A Central Role of Connexin 43 in Hypoxic Preconditioning
Lin, J. H.-C., Lou, N., Kang, N., Takano, T., Hu, F., Han, X., Xu, Q., Lovatt, D., Torres, A., Willecke, K., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3827-07.2008 · Cited by 169
Microglia release ATP by exocytosis: Microglia Exocytose ATP
Imura, Y., Morizawa, Y., Komatsu, R., Shibata, K., Shinozaki, Y., Kasai, H., Moriishi, K., Moriyama, Y., & Koizumi, S. (2013) · Glia · doi:10.1002/glia.22517 · Cited by 169
Rebola, N., Pinheiro, P. C., Oliveira, C. R., Malva, J. O., & Cunha, R. A. (2003) · Brain Research · doi:10.1016/s0006-8993(03)03247-5 · Cited by 165
Self-citationAdenosine: setting the stage for plasticity
Dias, R. B., Rombo, D. M., Ribeiro, J. A., Henley, J. M., & Sebastião, A. M. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2012.12.003 · Cited by 163
Cunha, R. A. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2007.06.026 · Cited by 163
Self-citationMatos, M., Augusto, E., Machado, N. J., dos Santos‐Rodrigues, A., Cunha, R. A., & Agostinho, P. M. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120469 · Cited by 162
Self-citationDuarte, J. M. N., Carvalho, R. A., Cunha, R. A., & Rolf Gruetter, A. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06349.x · Cited by 162
Self-citationGao, X., Qian, J., Zheng, S., Changyi, Y., Zhang, J., Ju, S., Zhu, J., & Li, C. (2014) · ACS Nano · doi:10.1021/nn5003375 · Cited by 162
Metabolic Downregulation: A Key to Successful Neuroprotection?
Yenari, M., Kitagawa, K., Lyden, P., & Perez-Pinzon, M. (2008) · Stroke · doi:10.1161/strokeaha.108.514471 · Cited by 162
Sweetened beverages, coffee, and tea and depression risk among older US adults
Guo, X., Park, Y., Freedman, N. D., Sinha, R., Hollenbeck, A. R., Blair, A., & Chen, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094715 · Cited by 161
Antidepressant effects of sleep deprivation require astrocyte-dependent adenosine mediated signaling
Hines, D. J., Schmitt, L. I., Hines, R. M., Moss, S. J., & Haydon, P. G. (2013) · Translational Psychiatry · doi:10.1038/tp.2012.136 · Cited by 160
Espinosa, J., da Rocha, A. S., Nunes, F., da Costa, M. S., Schein, V., Kazlauckas, V., Kalinine, E., Souza, D. O., Cunha, R. A., & Porciúncula, L. O. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-111982 · Cited by 160
Self-citationYu, L., Shen, H., Coelho, J. E., Araújo, I. M., Huang, Q., Day, Y., Rebola, N., Canas, P. M., Rapp, E. K., Ferrara, J., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21313 · Cited by 160
Self-citationDai, S.-S., Zhou, Y.-G., Li, W., An, J.-H., Li, P., Yang, N., Chen, X.-Y., Xiong, R.-P., Liu, P., Zhao, Y., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0268-10.2010 · Cited by 160
Canals, M., Burgueño, J., Marcellino, D., Cabello, N., Canela, E. I., Mallol, J., Agnati, L., Ferré, S., Bouvier, M., Fuxe, K., et al. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02200.x · Cited by 159
Production of Adenosine from Extracellular ATP at the Striatal Cholinergic Synapse
James, S., & Richardson, P. J. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb05841.x · Cited by 159
Phillis, J. W. (1995) · Brain Research · doi:10.1016/0006-8993(95)01153-6 · Cited by 159
Shen, H.-Y., Coelho, J. E., Ohtsuka, N., Canas, P. M., Day, Y.-J., Huang, Q.-Y., Rebola, N., Yu, L., Boison, D., Cunha, R. A., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5255-07.2008 · Cited by 159
Self-citationde Mendonça, A., Sebastião, A. M., & Ribeiro, A. J. (1995) · NeuroReport · doi:10.1097/00001756-199505300-00006 · Cited by 159
Endogenous neuroprotection: Mitochondria as gateways to cerebral preconditioning?
Dirnagl, U., & Meisel, A. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.02.017 · Cited by 158
Heterosynaptic long‐term depression mediated by ATP released from astrocytes
Chen, J., Tan, Z., Zeng, L., Zhang, X., He, Y., Gao, W., Wu, X., Li, Y., Bu, B., Wang, W., et al. (2013) · Glia · doi:10.1002/glia.22425 · Cited by 158
Adenosine A2A receptors modulate glutamate uptake in cultured astrocytes and gliosomes
Matos, M., Augusto, E., dos Santos‐Rodrigues, A., Schwarzschild, M. A., Chen, J., Cunha, R. A., & Agostinho, P. M. (2012) · Glia · doi:10.1002/glia.22290 · Cited by 158
Self-citationWeeding out bad waves: towards selective cannabinoid circuit control in epilepsy
Soltész, I., Alger, B. E., Kano, M., Lee, S.-H., Lovinger, D. M., Ohno‐Shosaku, T., & Watanabe, M. (2015) · Nature reviews. Neuroscience · doi:10.1038/nrn3937 · Cited by 157
Li, P., Rial, D., Canas, P. M., Yoo, J.-H., Li, W., Zhou, X., Wang, Y., van Westen, G. J. P., Payen, M.-P., Augusto, E., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.182 · Cited by 157
Self-citationAugusto, E., Matos, M., Sévigny, J., El‐Tayeb, A., Bynoe, M. S., Müller, C. E., Cunha, R. A., & Chen, J. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.5817-12.2013 · Cited by 156
Self-citationA Prospective Study of Coffee Drinking and Suicide in Women
Kawachi, I. I. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440050067008 · Cited by 155
Quantal Release of ATP in Mouse Cortex
Pankratov, Y., Lalo, U., Verkhratsky, A., & North, R. A. (2007) · The Journal of General Physiology · doi:10.1085/jgp.200609693 · Cited by 154
Matos, M., Shen, H.-Y., Augusto, E., Wang, Y., Wei, C. J., Wang, Y. T., Agostinho, P., Boison, D., Cunha, R. A., & Chen, J.-F. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.02.026 · Cited by 153
Self-citationAlhaider, I. A., Aleisa, A. M., Tran, T. T., Alzoubi, K. H., & Alkadhi, K. A. (2010) · SLEEP · doi:10.1093/sleep/33.4.437 · Cited by 153
Cunha, R. A., Correia‐de‐Sá, P., Sebastião, A. M., & Ribeiro, J. A. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15979.x · Cited by 153
Self-citationAdenosine Receptor Control of Cognition in Normal and Disease
Chen, J. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801022-8.00012-x · Cited by 152
Agresti, C., Meomartini, M. E., Amadio, S., Ambrosini, E., Volonté, C., Aloisi, F., & Visentin, S. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.12.005 · Cited by 152
Welihinda, A. A., Kaur, M., Greene, K., Zhai, Y., & Amento, E. P. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.02.010 · Cited by 152
Chen, X., Ghribi, O., & Geiger, J. D. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1376 · Cited by 151
A1R–A2AR heteromers coupled to Gs and Gi/0 proteins modulate GABA transport into astrocytes
Cristóvão‐Ferreira, S., Navarro, G., Brugarolas, M., Pérez‐Capote, K., Vaz, S. H., Fattorini, G., Conti, F., Lluís, C., Ribeiro, J. A., McCormick, P. J., et al. (2013) · Purinergic Signalling · doi:10.1007/s11302-013-9364-5 · Cited by 151
Modification upon aging of the density of presynaptic modulation systems in the hippocampus
Canas, P. M., Duarte, J. M. N., Rodrigues, R. J., Köfalvi, A., & Cunha, R. A. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.01.003 · Cited by 150
Self-citationCunha, R. A., Constantino, M. D., Sebastião, A. M., & Ribeiro, J. A. (1995) · Neuroreport · doi:10.1097/00001756-199507310-00029 · Cited by 148
Self-citationHigh Blood Caffeine Levels in MCI Linked to Lack of Progression to Dementia
Cao, C., Loewenstein, D., Lin, X., Zhang, C., Wang, L., Duara, R., Wu, Y., Giannini, A., Bai, G., Cai, J., et al. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111781 · Cited by 147
Vascular amyloidosis impairs the gliovascular unit in a mouse model of Alzheimer’s disease
Kimbrough, I. F., Robel, S., Roberson, E. D., & Sontheimer, H. W. (2015) · Brain · doi:10.1093/brain/awv327 · Cited by 146
Protecting Motor Neurons from Toxic Insult by Antagonism of Adenosine A2a and Trk Receptors
Mojsilovic‐Petrovic, J., Jeong, G., Crocker, A. J., Arneja, A., David, S., Russell, D., & Kalb, R. G. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.1856-06.2006 · Cited by 145
Purinergic modulation of [3H]GABA release from rat hippocampal nerve terminals
Cunha, R. A., & Ribeiro, J. A. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00237-3 · Cited by 145
Self-citationMayne, M. B., Fotheringham, J., Yan, H.-J., Power, C., Bigio, M. R. D., Peeling, J., & Geiger, J. D. (2001) · Annals of Neurology · doi:10.1002/ana.1010 · Cited by 145
Role of ATP in fast excitatory synaptic potentials in locus coeruleus neurones of the rat
Nieber, K., Poelchen, W., & Illés, P. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701386 · Cited by 145
Rex, C. S., Kramár, E. A., Colgin, L. L., Lin, B., Gall, C. M., & LYNCH, G. S. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.0880-05.2005 · Cited by 144
Murphree, L. J., Sullivan, G. W., Marshall, M. A., & Linden, J. M. (2005) · Biochemical Journal · doi:10.1042/bj20050888 · Cited by 144
Prediger, R. D., Pamplona, F. A., Fernandes, D., & Takahashi, R. N. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005341 · Cited by 141
A Long-Term Study of Istradefylline Safety and Efficacy in Patients With Parkinson Disease
Kondo, T., & Mizuno, Y. (2015) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000073 · Cited by 141
Yu, L., Huang, Z., Mariani, J., Wang, Y., Moskowitz, M. A., & Chen, J. (2004) · Nature Medicine · doi:10.1038/nm1103 · Cited by 139
Targeting mitochondrial ATP-sensitive potassium channels—a novel approach to neuroprotection
Busija, D. W., Lacza, Z., Rajapakse, N. C., Shimizu, K., Kis, B., Bari, F., Domoki, F., & Horiguchi, T. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.06.011 · Cited by 139
Neuroprotective Effects of Adenosine in Cerebral Ischemia: Window of Opportunity
Sweeney, M. I. (1997) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(96)00011-5 · Cited by 138
Pougnet, J.-T., Toulmé, E., Martínez, A., Choquet, D., Hosy, E., & Boué‐Grabot, É. (2014) · Neuron · doi:10.1016/j.neuron.2014.06.005 · Cited by 137
Tebano, M. T., Martire, A., Potenza, R. L., Grò, M. C., Pepponi, R., Armida, M., Domenici, M. R., Schwarzschild, M. A., Chen, J., & Popoli, P. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05046.x · Cited by 137
Lubitz, D. K. J. E. V., Lin, R. C. S., & Jacobson, K. A. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00498-x · Cited by 136
Batalha, V. L., Pego, J. M., Fontinha, B. M., Costenla, A. R., Valadas, J. S., Baqi, Y., Radjainia, H., Müller, C. E., Sebastião, A. M., & Lopes, L. V. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.8 · Cited by 136
Hameleers, P. A. H. M., Van Boxtel, M. P. J., Hogervorst, E., Riedel, W. J., Houx, P. J., Buntinx, F., & Jolles, J. (2000) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.218 · Cited by 134
Wiese, S., Jablonka, S., Holtmann, B., Orel, N., Rajagopal, R., Chao, M. V., & Sendtner, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705267104 · Cited by 134
Brambilla, R., Cottini, L., Fumagalli, M., Ceruti, S., & Abbracchio, M. P. (2003) · Glia · doi:10.1002/glia.10243 · Cited by 134
Working memory deficits in transgenic rats overexpressing human adenosine A2A receptors in the brain
Giménez‐Llort, L., Schiffmann, S. N., Shmidt, T., Canela, L., Camón, L., Wassholm, M., Canals, M., Terasmaa, A., Fernández‐Teruel, A., Tobeña, A., et al. (2006) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2006.05.004 · Cited by 133
Coffee Intake in Midlife and Risk of Dementia and its Neuropathologic Correlates
Gelber, R. P., Petrovitch, H., Masaki, K. H., Ross, G. W., & White, L. R. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-101428 · Cited by 133
Rogers, P. J., Heatherley, S. V., Hayward, R. C., Seers, H. E., Hill, J., & Kane, M. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2097-y · Cited by 132
Astrocytic function and its alteration in the epileptic brain
Jabs, R., Seifert, G., & Steinhäuser, C. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2008.01488.x · Cited by 132
A new neuromodulatory pathway with a glial contribution mediated via A2a adenosine receptors
Nishizaki, T., Nagai, K., Nomura, T., Tada, H., Kanno, T., Tozaki‐Saitoh, H., Li, X. X., Kondoh, T., Kodama, N., Takahashi, E., et al. (2002) · Glia · doi:10.1002/glia.10100 · Cited by 132
Striatal Pre- and Postsynaptic Profile of Adenosine A2A Receptor Antagonists
Orrù, M., Bakešová, J., Brugarolas, M., Quiroz, C., Beaumont, V., Goldberg, S. R., Lluı́s, C., Cortés, A., Franco, R., Casadó, V., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016088 · Cited by 132
Hauser, R. A., Olanow, C. W., Kieburtz, K. D., Pourcher, E., Axelerad, A. D., Lew, M., Kozyolkin, О. А., Neale, A. C., Resburg, C., Meya, U., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70148-6 · Cited by 132
Plamondon, H., Blondeau, N., Heurteaux, C., & Lazdunski, M. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199912000-00002 · Cited by 131
Duarte, J. M. N., Agostinho, P. M., Carvalho, R. A., & Cunha, R. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0021899 · Cited by 130 · cited 9×
“…disease (Arendash et al. 2006, 2009; Dall’Igna et al. 2007; Espinosa et al. 2013; Han et al. 2013; Laurent et al. 2014), diabetic neuropathy (Duarte et al. 2012), chronic repeated stress (Pechlivanova et al. 2012; Alzoubi et al. 2013; Kaster et al. 2015; Yin et al. 2015), sleep…”
BackgroundInfluentialSelf-citationCognato, G. D. P., Agostinho, P. M., Hockemeyer, J., Müller, C. E., Souza, D. O., & Cunha, R. A. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06465.x · Cited by 130
Self-citationDistinct Pathways of Desensitization of A1- and A2-Adenosine Receptors in DDT1 MF-2 Cells
Ramkumar, V., Olah, M. E., Jacobson, K. A., & Stiles, G. L. (1991) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)15379-0 · Cited by 130
Regulation of the Ecto-Nucleotidase Pathway in Rat Hippocampal Nerve Terminals
Cunha, R. A. (2001) · Neurochemical Research · doi:10.1023/a:1012392719601 · Cited by 129
Self-citationLoftfield, E., Freedman, N. D., Graubard, B. I., Guertin, K. A., Black, A., Huang, W., Shebl, F. M., Mayne, S. T., & Sinha, R. R. (2015) · American Journal of Epidemiology · doi:10.1093/aje/kwv146 · Cited by 129
Kobayashi, S., Zimmermann, H., & Millhorn, D. E. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.740621.x · Cited by 128
The Ubiquitin-Specific Protease Usp4 Regulates the Cell Surface Level of the A2a Receptor
Milojević, T., Reiterer, V., Stefan, E., Korkhov, V. M., Dorostkar, M. M., Ducza, E., Ogris, E., Boehm, S., Freissmuth, M., & Nanoff, C. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.015818 · Cited by 128
Huang, C.-C., Liang, Y.-C., & Hsu, K.-S. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-22-09728.1999 · Cited by 127
Adenosine A2A Receptors and Parkinson’s Disease
Morelli, M., Carta, A. R., & Jenner, P. G. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-89615-9_18 · Cited by 127
Matos, M., Augusto, E., Agostinho, P. M., Cunha, R. A., & Chen, J. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.1828-13.2013 · Cited by 127
Self-citationFontinha, B. M., Diógenes, M. J., Ribeiro, J. A., & Sebastião, A. M. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.01.011 · Cited by 127
Receptor subtypes mediating adenosine-induced dilation of cerebral arterioles
Ngai, A. C., Coyne, E. F., Meno, J. R., West, G. A., & Winn, H. R. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.280.5.h2329 · Cited by 127
Adenosine, Caffeine, and Performance: From Cognitive Neuroscience of Sleep to Sleep Pharmacogenetics
Urry, E., & Landolt, H. (2014) · Current topics in behavioral neurosciences · doi:10.1007/7854_2014_274 · Cited by 126
Wall, M. J., & Dale, N. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2013.253450 · Cited by 123
Svenningsson, P., Lindskog, M., Rognoni, F., Fredholm, B. B., Greengard, P., & Fisone, G. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00510-1 · Cited by 123
Lambert, N. A., & Teyler, T. J. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90190-5 · Cited by 123
The effects of age on the response to caffeine
Swift, C. G., & Tiplady, B. (1988) · Psychopharmacology · doi:10.1007/bf00735876 · Cited by 123
Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation
Ingwersen, J., Wingerath, B., Graf, J., Lepka, K., Hofrichter, M., Schröter, F., Wedekind, F., Bauer, A., Schrader, J., Hartung, H. ‐., et al. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0512-z · Cited by 123
Rebola, N., Rodrigues, R. J., Lopes, L. V., Richardson, P. J., Oliveira, C. R., & Cunha, R. A. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.01.054 · Cited by 122
Self-citationda Costa, M. S., Botton, P. H. S., Mioranzza, S., Souza, D. O., & Porciúncula, L. O. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.03.038 · Cited by 122
Shen, H., Li, T., & Boison, D. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2009.02248.x · Cited by 122
Rebola, N., Coelho, J. E., Costenla, A. R., Lopes, L. V., Parada, A., Oliveira, C. R., Soares-da-Silva, P., de Mendonça, A., & Cunha, R. A. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02815.x · Cited by 122
Self-citationMelani, A., Pantoni, L., Bordoni, F., Gianfriddo, M., Bianchi, L., Vannucchi, M. G., Bertorelli, R., Monopoli, A., & Pedata, F. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03753-8 · Cited by 121
Seidel, M. G., Klinger, M., Freissmuth, M., & Höeller, C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25833 · Cited by 121
Varani, K., Vincenzi, F., Tosi, A., Gessi, S., Casetta, I., Granieri, G., Fazio, P., Leung, E., MacLennan, S., Granieri, E., et al. (2009) · The FASEB Journal · doi:10.1096/fj.09-141044 · Cited by 121
Ruusunen, A. A., Lehto, S. M., Tolmunen, T., Mursu, J., Kaplan, G. A., & Voutilainen, S. (2010) · Public Health Nutrition · doi:10.1017/s1368980010000509 · Cited by 121
Pankratov, Y. V., Lalo, U., Krishtal, O., & Verkhratsky, A. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2002.021956 · Cited by 120
Andersson, M., Blomstrand, F., & Hanse, E. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.142737 · Cited by 120
Differential effects of adenosine receptor subtypes on release and reuptake of hippocampal serotonin
Okada, M., 河田, 祐., Murakami, T., Wada, K., Mizuno, K., Kondo, T., & Kaneko, S. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00415.x · Cited by 119
Che, J., Chan, E. S. L., & Cronstein, B. N. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.038760 · Cited by 119
Pandolfo, P., Machado, N. J., Köfalvi, A., Takahashi, R. N., & Cunha, R. A. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.04.011 · Cited by 118
Self-citationBorycz, J., Pereira, M. F., Melani, A., Rodrigues, R. J., Köfalvi, A., Panlilio, L. V., Pedata, F., Goldberg, S. R., Cunha, R. A., & Ferré, S. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04386.x · Cited by 118
Self-citationMcIntire, W. E., MacCleery, G., & Garrison, J. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011233200 · Cited by 117
Increased PKA signaling disrupts recognition memory and spatial memory: role in Huntington's disease
Giralt, A., Saavedra, A., Carretón, O., Xifró, X., Alberch, J., & Pérez‐Navarro, E. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr351 · Cited by 117
A2A Adenosine Receptor Regulates the Human Blood-Brain Barrier Permeability
Kim, D.-G., & Bynoe, M. S. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8879-2 · Cited by 116
Pham, N. M., Nanri, A., Kurotani, K., Kuwahara, K., Kume, A., Sato, M., Hayabuchi, H., & Mizoue, T. (2013) · Public Health Nutrition · doi:10.1017/s1368980013000360 · Cited by 116
Rudolphi, K. A., Keil, M., Fastbom, J., & Fredholm, B. B. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90112-2 · Cited by 116
Cunha, G. M. A., Canas, P. M., Melo, C. S., Hockemeyer, J., Müller, C. E., Oliveira, C. R., & Cunha, R. A. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.11.013 · Cited by 115
Self-citationNerve growth factor (NGF) expression in rat microglia is induced by adenosine A2a-receptors
Heese, K., Fiebich, B. L., Bauer, J., & Otten, U. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00545-4 · Cited by 114
Blondeau, N., Plamondon, H., Richelme, C., Heurteaux, C., & Lazdunski, M. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00304-3 · Cited by 113
Fiebich, B. L., Biber, K. P. H., Gyufko, K., et al. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66041426.x · Cited by 113
Berman, R. F., Fredholm, B. B., Ådén, U., & O'Connor, W. T. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02441-0 · Cited by 113
Prediger, R. D., Fernandes, D., & Takahashi, R. N. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.10.017 · Cited by 113
Frenguelli, B. G., Llaudet, E., & Dale, N. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01957.x · Cited by 112
Regulation of Fear Responses by Striatal and Extrastriatal Adenosine A2A Receptors in Forebrain
Wei, C. J., Augusto, E., Gomes, C. A., Singer, P., Wang, Y., Boison, D., Cunha, R. A., Yee, B. K., & Chen, J. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.05.003 · Cited by 112
Self-citationd’Alcantara, P., Ledent, C. A., Swillens, S., & Schiffmann, S. N. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00372-4 · Cited by 112
The Adenosine A2A Receptor Interacts with the Actin-binding Protein α-Actinin
Burgueño, J., Blake, D. J., Benson, M. A., Tinsley, C. L., Esapa, C. T., Canela, E. I., Penela, P., Mallol, J., Mayor, F., Lluís, C., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302809200 · Cited by 110
Spasić, M. R., Callaerts, P., & Norga, K. K. (2009) · The Neuroscientist · doi:10.1177/1073858408327805 · Cited by 109
Li, W., Dai, S.-S., An, J., Li, P., Chen, X., Xiong, R., Liu, P., Wang, H., Zhao, Y., Zhu, M., et al. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.11.020 · Cited by 109
Gyoneva, S., Shapiro, L. P., Lazo, C. R., Garnier‐Amblard, E. C., Smith, Y., Miller, G. W., & Traynelis, S. F. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.03.004 · Cited by 109
Cunha, G. M. A., Canas, P. M., Oliveira, C. R., & Cunha, R. A. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.05.024 · Cited by 108
Self-citationPhillis, J. W. (2004) · Critical Reviews in Neurobiology · doi:10.1615/critrevneurobiol.v16.i4.20 · Cited by 108
Lauro, C., Cipriani, R., Catalano, M., Trettel, F., Chece, G., Brusadin, V., Antonilli, L., van Rooijen, N., Eusebi, F., Fredholm, B. B., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.26 · Cited by 108
Changes in synaptosomal ectonucleotidase activities in two rat models of temporal lobe epilepsy
Bonan, C. D., Walz, R., Pereira, G. S., Worm, P. V., Battastini, A. M. O., Cavalheiro, É. A., Izquierdo, I., & Sarkis, J. J. F. (2000) · Epilepsy Research · doi:10.1016/s0920-1211(00)00095-4 · Cited by 107
Characterization and Expression of the Human A2a Adenosine Receptor Gene
Peterfreund, R. A., MacCollin, M., Gusella, J. F., et al. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66010362.x · Cited by 107
Schock, S., Nzau, M., Yakubchyk, Y., Sabourin, L. A., Hakim, A. M., Ventureyra, E. C. G., & Thompson, C. S. (2007) · Brain Research · doi:10.1016/j.brainres.2007.06.070 · Cited by 107
Brundege, J. M., & Dunwiddie, T. V. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-18-05603.1996 · Cited by 106
Villar-Menéndez, I., Porta, S., Buira, S. P., Pereira‐Veiga, T., Díaz-Sánchez, S., Albasanz, J. L., Ferrer, I., Martín, M., & Barrachina, M. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.05.030 · Cited by 106
Chronic administration of selective adenosine A1 receptor agonist or antagonist in cerebral ischemia
Lubitz, D. K. J. E. V., Lin, R. C.-S., Melman, N., Ji, X., Carter, M. F., & Jacobson, K. A. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90241-0 · Cited by 106
Synchronization of Ca2+ oscillations: involvement of ATP release in astrocytes
Koizumi, S. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07438.x · Cited by 106
Green, R. M., & Stiles, G. L. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112280 · Cited by 106
Nonsynaptic and nonvesicular ATP release from neurons and relevance to neuron–glia signaling
Fields, R. D. (2011) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2011.02.009 · Cited by 106
Adenosine Formation and Release by Embryonic Chick Neurons and Glia in Cell Culture
Meghji, P., Tuttle, J. B., & Rubio, R. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09252.x · Cited by 105
Kim, C. S., & Johnston, D. (2015) · Journal of Neurophysiology · doi:10.1152/jn.00951.2014 · Cited by 105
Umemiya, M., & Berger, A. J. (1994) · Neuron · doi:10.1016/0896-6273(94)90429-4 · Cited by 104
A1 and A2A adenosine receptors and A1 mRNA in mouse brain: effect of long-term caffeine treatment
Johansson, B., Georgiev, V., Lindström, K., & Fredholm, B. B. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00378-8 · Cited by 104
Lucas, M., O’Reilly, E. J., Pan, A., Mirzaei, F., Willett, W. C., Okereke, O. I., & Ascherio, A. (2014) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.795243 · Cited by 103
Dias, R. B., Ribeiro, J. A., & Sebastião, A. M. (2010) · Hippocampus · doi:10.1002/hipo.20894 · Cited by 103
Caffeine, cognitive failures and health in a non‐working community sample
Smith, A. P. (2009) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.991 · Cited by 102
Rebola, N., Sebastião, A. M., de Mendonça, A., Oliveira, C. R., Ribeiro, J. A., & Cunha, R. A. (2003) · Journal of Neurophysiology · doi:10.1152/jn.00896.2002 · Cited by 101
Self-citationTuning and Fine-Tuning of Synapses with Adenosine
Sebastião, A. M., & Ribeiro, J. A. (2009) · Current Neuropharmacology · doi:10.2174/157015909789152128 · Cited by 101
Functional and Anatomical Identification of a Vesicular Transporter Mediating Neuronal ATP Release
Larsson, M., Sawada, K., Morland, C., Hiasa, M., Ormel, L., Moriyama, Y., & Gundersen, V. (2011) · Cerebral Cortex · doi:10.1093/cercor/bhr203 · Cited by 101
Georgiev, V., Johansson, B., & Fredholm, B. B. (1993) · Brain Research · doi:10.1016/0006-8993(93)91672-f · Cited by 100
Heterodimeric adenosine receptors: a device to regulate neurotransmitter release
Ciruela, F., Ferré, S., Casadó, V., et al. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6216-2 · Cited by 100
Adenosine stimulates glycolytic flux in isolated perfused rat hearts by A1-adenosine receptors
Wyatt, D. A., Edmunds, M. C., Rubio, R., Berne, R. M., Lasley, R. D., & Mentzer, R. M. (1989) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1989.257.6.h1952 · Cited by 100
Chung, H. J., Ge, W., Qian, X., Wiser, O., Jan, Y. N., & Jan, L. Y. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811685106 · Cited by 99
Melani, A., Corti, F., Stephan, H., Müller, C. E., Donati, C., Bruni, P., Vannucchi, M. G., & Pedata, F. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.09.036 · Cited by 99
Arab, L., Biggs, M. L., O'Meara, E. S., Longstreth, W. T., Crane, P. K., & Fitzpatrick, A. L. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-110431 · Cited by 98
Revan, S., Montesinos, M. C., Naime, D., Landau, S., & Cronstein, B. N. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.29.17114 · Cited by 98
Madeira, M. H., Elvas, F., Boia, R., Gonçalves, F. Q., Cunha, R. A., Ambrósio, A. F., & Santiago, A. R. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0333-5 · Cited by 97
Self-citationPreladenant as an Adjunctive Therapy With Levodopa in Parkinson Disease
Hauser, R. A., Stocchi, F., Rascol, O., Huyck, S. B., Capece, R., Ho, T. W., Sklar, P. A., Lines, C., Michelson, D., & Hewitt, D. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.2268 · Cited by 97
Adenosine A 2 A receptors are necessary and sufficient to trigger memory impairment in adult mice
Pagnussat, N., Almeida, A. S., Marques, D. M., Nunes, F., Chenet, G. C., Botton, P. H. S., Mioranzza, S., Loss, C. M., Cunha, R. A., & Porciúncula, L. O. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13180 · Cited by 97
Self-citationDesensitisation of the Adenosine A1 Receptor by the A2A Receptor in the Rat Striatum
Dixon, A. K., Widdowson, L., & Richardson, P. J. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69010315.x · Cited by 97
Adenosine A2A receptor gene disruption protects in an α‐synuclein model of Parkinson's disease
Kachroo, A., & Schwarzschild, M. A. (2011) · Annals of Neurology · doi:10.1002/ana.22630 · Cited by 97
Gubitz, A. K., Widdowson, L., Kurokawa, M., Kirkpatrick, K. A., & Richardson, P. J. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67010374.x · Cited by 97
Marchi, M., Raiteri, L., Risso, F., Vallarino, A., Bonfanti, A., Monopoli, A., Ongini, E., & Raiteri, M. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704712 · Cited by 96
Diógenes, M. J., Assaife‐Lopes, N., Pinto‐Duarte, A., Ribeiro, J. A., & Sebastião, A. M. (2007) · Hippocampus · doi:10.1002/hipo.20294 · Cited by 96
Lopes, L. V., Cunha, R. A., & Ribeiro, J. A. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.731733.x · Cited by 96
Self-citationActivity-Dependent Release of Adenosine: A Critical Re-Evaluation of Mechanism
Wall, M. J., & Dale, N. (2008) · Current Neuropharmacology · doi:10.2174/157015908787386087 · Cited by 96
Rebola, N., Porciúncula, L. O., Lopes, L. V., Oliveira, C. R., Soares-da-Silva, P., & Cunha, R. A. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.01026.x · Cited by 96
Self-citationPinto‐Duarte, A., Coelho, J. E., Cunha, R. A., Ribeiro, J. A., & Sebastião, A. M. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03071.x · Cited by 95
Self-citationXiao, D., Bastia, E., Xu, Y., Benn, C., Cha, J.-H. J., Peterson, T. S., Chen, J., & Schwarzschild, M. A. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3554-06.2006 · Cited by 95
Adenosine A2AReceptors Modulate α-Synuclein Aggregation and Toxicity
Ferreira, D. G., Batalha, V. L., Miranda, H. V., Coelho, J. E., Gomes, R., Gonçalves, F. Q., Real, J. I., Rino, J., Albino‐Teixeira, A., Cunha, R. A., et al. (2015) · Cerebral Cortex · doi:10.1093/cercor/bhv268 · Cited by 95
Self-citationKW-6002 protects from MPTP induced dopaminergic toxicity in the mouse
Pierri, M., Vaudano, E., Sager, T. N., & Englund, U. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.11.009 · Cited by 94
Etherington, L. V., Patterson, G. E., Meechan, L., Boison, D., Irving, A. J., Dale, N., & Frenguelli, B. G. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.09.016 · Cited by 94
Melani, A., Cipriani, S., Vannucchi, M. G., Nosi, D., Donati, C., Bruni, P., Giovannini, M. G., & Pedata, F. (2009) · Brain · doi:10.1093/brain/awp076 · Cited by 94
Biber, K. P. H., Pinto‐Duarte, A., Wittendorp, M. C., Dolga, A. M., Fernandes, C. C., Künzel, J. V. F. D., Keijser, J. N., de Vries, R., IJzerman, A. P., Ribeiro, J. A., et al. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301612 · Cited by 93
Modification of adenosine modulation of synaptic transmission in the hippocampus of aged rats
Sebastião, A. M., Cunha, R. A., de Mendonça, A., & Ribeiro, J. A. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703736 · Cited by 93
Self-citationCoffee Consumption and Risk of Stroke in Women
Larsson, S. C., Virtamo, J., & Wolk, A. (2011) · Stroke · doi:10.1161/strokeaha.110.603787 · Cited by 93
Adenosine A2A Receptors in the Amygdala Control Synaptic Plasticity and Contextual Fear Memory
Simões, A. P., Machado, N. J., Gonçalves, N., Kaster, M. P., Simões, A. T., Nunes, A. F., de Almeida, L. P., Goosens, K. A., Rial, D., & Cunha, R. A. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.98 · Cited by 93
Self-citationChen, J., & Chern, Y. (2010) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-13443-2_10 · Cited by 92
Identification of A2a Adenosine Receptor Domains Involved in Selective Coupling to GS
Olah, M. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.1.337 · Cited by 92
Sonsalla, P. K., Wong, L., Harris, S. L., Richardson, J. R., Khobahy, I., Li, W., Gadad, B. S., & German, D. C. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.01.022 · Cited by 92
Viosca, J., Malleret, G., Bourtchouladze, R., Benito, E., Vronskava, S., Kandel, E. R., & Barco, Á. (2009) · Learning & Memory · doi:10.1101/lm.1220309 · Cited by 92
Gonçalves, N., Simões, A. T., Cunha, R. A., & de Almeida, L. P. (2013) · Annals of Neurology · doi:10.1002/ana.23866 · Cited by 92
Self-citationMarchi, M., Raiteri, L., Risso, F., Vallarino, A., Bonfanti, A., Monopoli, A., Ongini, E., & Raiteri, M. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704857 · Cited by 91
Melani, A., Gianfriddo, M., Vannucchi, M. G., Cipriani, S., Baraldi, P. G., Giovannini, M. G., & Pedata, F. (2006) · Brain Research · doi:10.1016/j.brainres.2005.12.010 · Cited by 91
Marini, A. M., Jiang, X., Wu, X., Pan, H., Guo, Z., Mattson, M. P., Blondeau, N., Novelli, A., & Lipsky, R. H. (2006) · Amino Acids · doi:10.1007/s00726-006-0414-y · Cited by 91
Minghetti, L., Greco, A., Potenza, R. L., Pèzzola, A., Blum, D. L., Bantubungi, K., & Popoli, P. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3180517477 · Cited by 91
Li, W., Silva, H. B. L., Real, J. I., Wang, Y., Rial, D., Li, P., Payen, M.-P., Zhou, Y., Müller, C. E., Tomé, Â. R., et al. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.03.030 · Cited by 91
Self-citationPires, V. A., Pamplona, F. A., Pandolfo, P., Fernandes, D., Prediger, R. D., & Takahashi, R. N. (2009) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32832a80bf · Cited by 90
Wang, H., Guan, W., Yang, W., Wang, Q., Zhao, H., Yang, F., Lv, X., & Li, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092482 · Cited by 89
Adenosine A1 Receptor Inhibition of Glutamate Exocytosis and Protein Kinase C‐Mediated Decoupling
Banie, A. P., & Nicholls, D. G. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03257.x · Cited by 89
Sohail, M. A., Hashmi, A. Z., Hakim, W., Watanabe, A., Zipprich, A., Groszmann, R. J., Dranoff, J. A., Torok, N. J., & Mehal, W. Z. (2008) · Hepatology · doi:10.1002/hep.22589 · Cited by 89
Dr. Jekyll/Mr. Hyde: the dual role of extracellular ATP
Virgilio, F. D. (2000) · Journal of the Autonomic Nervous System · doi:10.1016/s0165-1838(00)00114-4 · Cited by 89
Haselkorn, M. L., Shellington, D. K., Jackson, E. K., Vagni, V., Janesko‐Feldman, K. L., Dubey, R. K., Gillespie, D. G., Cheng, D., Bell, M. J., Jenkins, L. W., et al. (2010) · Journal of Neurotrauma · doi:10.1089/neu.2009.1075 · Cited by 89
Adenosine A2A receptor interactions with receptors for other neurotransmitters and neuromodulators
Ribeiro, J. A. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00230-7 · Cited by 89
Chiang, M., Lee, Y., Huang, C., & Chern, Y. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413279200 · Cited by 89
An Overview of Adenosine A2A Receptor Antagonists in Parkinson's Disease
Jenner, P. G. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801022-8.00003-9 · Cited by 89
The A2A‐adenosine receptor: a GPCR with unique features?
Zezula, J., & Freissmuth, M. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707674 · Cited by 88
Adenosine receptors interacting proteins (ARIPs): Behind the biology of adenosine signaling
Ciruela, F., Albergaria, C., Soriano, A., Cuffí, M. L., Carbonell, L., Sánchez, S., Gandía, J., & Fernández‐Dueñas, V. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2009.10.016 · Cited by 88
Borroto‐Escuela, D. O., Romero‐Fernandez, W., Tarakanov, A. O., Ciruela, F., Agnati, L. F., & Fuxé, K. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.01.022 · Cited by 88
Chern, Y., Lai, H. L., Fong, J. C., & Liang, Y. T. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13292-6 · Cited by 87
Rivkees, S. A., & Wendler, C. C. (2011) · Pediatric Research · doi:10.1203/pdr.0b013e31820efbcf · Cited by 86
Chiang, M., Chen, H., Lai, H., Chen, H.-W., Chou, S., Chen, C., Tsai, F., & Chern, Y. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp230 · Cited by 86
Mills, J. H., Alabanza, L. M., Mahamed, D., & Bynoe, M. S. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-193 · Cited by 86
What Characterizes Late-Life Depression?
Ismail, Z., Fischer, C. E., & McCall, W. V. (2013) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2013.08.010 · Cited by 85
Wetherington, J. P., & Lambert, N. A. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-04-01248.2002 · Cited by 85
Orellana, J. A., Montero, T. D., & Rommy von Bernhardi, M. (2013) · Glia · doi:10.1002/glia.22573 · Cited by 84
Choi, I.-Y., Lee, J., Ju, C., Hwang, S., Cho, G., Lee, H. W., Choi, W. J., Jeong, L. S., & Kim, W.-K. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.07.006 · Cited by 84
Xu, K., Luca, D. G. D., Orrù, M., Xu, Y., Chen, J., & Schwarzschild, M. A. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.02.035 · Cited by 84
Aging, caffeine, and information processing: an event-related potential analysis
Lorist, M. M., Snel, J., Mulder, G., & Kok, A. (1995) · Electroencephalography and Clinical Neurophysiology/Evoked Potentials Section · doi:10.1016/0168-5597(95)00069-5 · Cited by 83
Terrian, D. M., Hernandez, P., Rea, M. A., & Peters, R. I. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb08529.x · Cited by 83
Neuroprotective effects of caffeine in the model of 6-hydroxydopamine lesion in rats
Aguiar, L. M. V., Júnior, H. V. N., Macêdo, D. S., Oliveira, A. A., de Freitas, R. M., Vasconcelos, S. M. M., Cunha, G. M. A., de Sousa, F. C. F., & Viana, G. S. D. B. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.05.027 · Cited by 82
Gundlfinger, A., Bischofberger, J., Johenning, F. W., Torvinen, M., Schmitz, D., & Breustedt, J. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.132613 · Cited by 81
Cited by
Pharmacology of Adenosine Receptors: The State of the Art
Borea, P. A., Gessi, S., Merighi, S., Vincenzi, F., & Varani, K. (2018) · Physiological Reviews · doi:10.1152/physrev.00049.2017 · Cited by 783
Interindividual Differences in Caffeine Metabolism and Factors Driving Caffeine Consumption
Nehlig, A. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014407 · Cited by 632
The adenosine pathway in immuno-oncology
Allard, B., Allard, D., Buisseret, L., & Stagg, J. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0382-2 · Cited by 586
Purinergic Signalling: Therapeutic Developments
Burnstock, G. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00661 · Cited by 398
Mental Fatigue Impairs Endurance Performance: A Physiological Explanation
Martin, K., Meeusen, R., Thompson, K. G., Keegan, R., & Rattray, B. (2018) · Sports Medicine · doi:10.1007/s40279-018-0946-9 · Cited by 257
Metadata
- Authors
- Cunha, R. A.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2016-08-16
- Volume
- 139
- Issue
- 6
- Pages
- 1019-1055
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2472172082
- Cited by
- 441
- References
- 642
- FWCI
- 30.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.